Raloxifene neutralizes bone brittleness induced by anti-remodeling treatment and increases fatigue life through non-cell mediated mechanisms. Actualizaciones en Osteología, [S. l.], v. 12, n. 3, p. 169–179, 2024. Disponível em: https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/310. Acesso em: 11 oct. 2026.